BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 8
• 9
• 10
• 11
• 12
• 13
• 15
• 16
• 17
• 18
• 19
• 20
• 22
• 23
• 24
• 25
• 26
• 27

• Press Releases

  Novavax Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights

  February 26, 2026

   · 

  20 min read
• Press Releases

  Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs

  February 26, 2026

   · 

  11 min read
• Press Releases

  SK bioscience, IDT Biologika and Vaxxas Selected for Next-Generation Influenza Vaccine development Financed by the European Union

  February 26, 2026

   · 

  7 min read
• Press Releases

  Eisai and Advocacy Leaders Launch “Kompass,” a Digital Destination to Help Patients and Caregivers Navigate the Complexities of Kidney Cancer

  February 26, 2026

   · 

  6 min read
• Press Releases

  Prospective Multicenter Registry Study Reports High Local Tumor Control Following Resection with GammaTile® in Newly Diagnosed Brain Metastases

  February 26, 2026

   · 

  4 min read
• Press Releases

  Aramis Biotechnologies announces the achievement of an important milestone with the start of a Phase 1/2 clinical trial of its vaccine in development against seasonal influenza in 728 participants

  February 26, 2026

   · 

  2 min read
• Press Releases

  Viridian Therapeutics Highlights Recent Progress and Reports Fourth Quarter and Full Year 2025 Financial Results

  February 26, 2026

   · 

  13 min read
• Press Releases

  ImmunityBio Completes Enrollment in Pivotal Randomized Trial Evaluating ANKTIVA® Plus BCG Versus BCG Alone in BCG-Naïve Non-Muscle Invasive Bladder Cancer Carcinoma In Situ

  February 26, 2026

   · 

  8 min read
• Press Releases

  10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders

  February 26, 2026

   · 

  12 min read
• Press Releases

  Evox Therapeutics Partners with Rett Syndrome Research Trust to Evaluate ExoEdit® Technology to Enable Gene Editing in Rett Syndrome

  February 26, 2026

   · 

  3 min read